|
Zoledronic Acid Protects Bones of Women Getting Breast Cancer Treatment
|
|
|
Posted on
Aug 21 2008 1:42 AM
by
adeal
|
Zoledronic acid prevents bone loss in breast cancer patients undergoing endocrine therapy and improves bone mineral density after treatment, according to an Austrian study. Adjuvant endocrine therapy is widely used in patients with endocrine-responsive early breast cancer, but the treatment causes bone loss in premenopausal women.
|
|
No comment found for this blog
|
|